Primary pulmonary hypertension, Lancet Lond Engl, vol.352, issue.9129, pp.719-744, 1998. ,
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), Eur Heart J, pp.2493-537, 1920. ,
Anxiety and depression in patients with pulmonary hypertension, Psychosom Med, vol.66, issue.6, pp.831-837, 2004. ,
Principles of Rehabilitation and Reactivation, Respiration, vol.89, issue.1, pp.2-11, 2015. ,
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension, Circulation, vol.114, issue.14, pp.1482-1491, 2006. ,
Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension, Respiration, vol.81, issue.5, pp.394-401, 2011. ,
Safety and efficacy of exercise training in various forms of pulmonary hypertension, Eur Respir J, vol.40, issue.1, pp.84-92, 2012. ,
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension, Eur Respir J, vol.34, issue.3, pp.669-75, 2009. ,
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review, Eur Respir J, vol.34, issue.4, pp.888-94, 2009. ,
Definitions and diagnosis of pulmonary hypertension, J Am Coll Cardiol, vol.62, pp.42-50, 1925. ,
Pulmonary Hypertension. Dtsch Ärztebl Int, vol.114, pp.73-84, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01969356
Primary pulmonary hypertension : report on a WHO meeting, pp.15-17, 1973. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, issue.1, p.1801913, 2019. ,
Relevant issues in the pathology and pathobiology of pulmonary hypertension, J Am Coll Cardiol, vol.62, pp.4-12, 1925. ,
Pulmonary Arterial Hypertension: Pathophysiology and Treatment. Diseases [Internet], vol.6, 2018. ,
A global view of pulmonary hypertension, Lancet Respir Med, vol.4, issue.4, pp.306-328, 2016. ,
An epidemiological study of pulmonary arterial hypertension, Eur Respir J, vol.30, issue.1, pp.104-113, 2007. ,
Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, vol.173, issue.9, pp.1023-1053, 2006. ,
Survival in pulmonary hypertension in Spain: insights from the Spanish registry, Eur Respir J, vol.40, issue.3, pp.596-603, 2012. ,
Primary pulmonary hypertension. A national prospective study, Ann Intern Med, vol.107, issue.2, pp.216-239, 1987. ,
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension, Respir Res, vol.11, p.73, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00668454
Incidence and prevalence of pulmonary arterial hypertension in Germany, Int J Cardiol, vol.203, pp.612-615, 2016. ,
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry, Int J Cardiol, vol.168, issue.2, pp.871-80, 2013. ,
Chronic thromboembolic pulmonary hypertension, Lancet Respir Med, vol.2, issue.7, pp.573-82, 2014. ,
ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the, ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), 2015. ,
, Eur Heart J, vol.37, issue.1, pp.67-119, 2016.
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension, N Engl J Med, vol.369, issue.4, pp.319-348, 2013. ,
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism, Thromb Res, vol.124, issue.3, pp.256-264, 2009. ,
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism, Chest, vol.130, issue.1, pp.172-177, 2006. ,
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, vol.350, issue.22, pp.2257-64, 2004. ,
Pulmonary embolism: oneyear follow-up with echocardiography doppler and five-year survival analysis. Circulation, vol.99, pp.1325-1355, 1999. ,
Chronic thromboembolic pulmonary hypertension, Swiss Med Wkly, vol.148, p.14702, 201817. ,
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension, Am J Respir Crit Care Med, vol.177, issue.10, pp.1122-1129, 2008. ,
Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany, Clin Res Cardiol Off J Ger Card Soc, vol.107, issue.7, pp.548-53, 2018. ,
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry, Circulation, vol.124, issue.18, pp.1973-81, 2011. ,
Diagnosis of chronic thromboembolic pulmonary hypertension, Eur Respir Rev, vol.26, issue.143, p.160108, 2017. ,
An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.143, 2017. ,
Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, issue.9, pp.892-898, 2012. ,
Genetics and genomics of pulmonary arterial hypertension, J Am Coll Cardiol, vol.62, pp.13-21, 1925. ,
URL : https://hal.archives-ouvertes.fr/hal-02137830
, Pulmonary Arterial Hypertension Symptoms, Causes and Risk Factors
, American Lung Association, 2019.
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension, Thromb Haemost, vol.93, issue.3, pp.512-518, 2005. ,
Splenectomy and chronic thromboembolic pulmonary hypertension, Thorax, vol.60, issue.12, pp.1031-1035, 2005. ,
Risk factors for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.33, issue.2, pp.325-356, 2009. ,
The pathophysiology of chronic thromboembolic pulmonary hypertension, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.143, 2017. ,
Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from, Hum Pathol, vol.34, issue.12, pp.1290-1298, 1990. ,
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation, vol.123, issue.16, pp.1788-830, 2011. ,
Nouveau regard sur la physiopathologie de l'hypertension artérielle pulmonaire, Rev Mal Respir, vol.36, issue.4, pp.433-440, 2019. ,
Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled, Eur Respir Rev Off J Eur Respir Soc, vol.26, issue.146, 2017. ,
Pulmonary Vascular Stiffness: Measurement, Modeling, and Implications in Normal and Hypertensive Pulmonary Circulations, Compr Physiol, vol.1, issue.3, pp.1413-1448, 2011. ,
In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug, Circulation, vol.133, issue.18, pp.1783-94, 2016. ,
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, issue.1, 2019. ,
Cellular and molecular basis of pulmonary arterial hypertension, J Am Coll Cardiol, vol.54, issue.1, pp.20-31, 2009. ,
Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension, Arterioscler Thromb Vasc Biol, vol.36, issue.6, pp.1293-301, 2016. ,
Update on chronic thromboembolic pulmonary hypertension, Trends Cardiovasc Med, vol.27, issue.1, pp.29-37, 2017. ,
Diagnosis of pulmonary hypertension, Eur Respir J [Internet, vol.53, issue.1, 2019. ,
Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis ,
, Dtsch Med Wochenschr, vol.139, issue.33, pp.1647-52, 1946.
Chronic pulmonary embolism: diagnosis. Cardiovasc Diagn Ther, vol.8, pp.253-71, 2018. ,
Initial dual oral combination therapy in pulmonary arterial hypertension, Eur Respir J, vol.47, issue.6, pp.1727-1763, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01301539
Treatment of pulmonary arterial hypertension, N Engl J Med, vol.351, issue.14, pp.1425-1461, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01455600
Pulmonary hypertension: current diagnosis and treatment, Clin Res Cardiol Off J Ger Card Soc, vol.96, issue.8, pp.527-568, 2007. ,
Treatment of pulmonary hypertension, Lancet Respir Med, vol.4, issue.4, pp.323-359, 2016. ,
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry, Chest, vol.142, issue.2, pp.448-56, 2012. ,
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension, N Engl J Med, vol.373, issue.9, pp.834-878, 2015. ,
Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med, vol.369, issue.9, pp.809-827, 2013. ,
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis, Lancet Respir Med, vol.4, issue.4, pp.291-305, 2016. ,
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study, Eur Respir J, vol.43, issue.6, pp.1691-1698, 2014. ,
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy, J Am Coll Cardiol, vol.58, issue.24, pp.2511-2520, 2011. ,
Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients, Ann Thorac Surg, vol.94, issue.1, pp.97-103, 2012. ,
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort, Circulation, vol.133, issue.18, pp.1761-71, 2016. ,
Clinical classification of pulmonary hypertension, J Am Coll Cardiol, vol.43, issue.12, pp.5-12, 2004. ,
Primary pulmonary hypertension, N Engl J Med, vol.336, issue.2, pp.111-118, 1997. ,
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry, Ann Intern Med, vol.115, issue.5, pp.343-352, 1991. ,
Risk stratification and medical therapy of pulmonary arterial hypertension, Eur Respir J, vol.53, issue.1, 2019. ,
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension, Eur Respir J, vol.50, issue.2, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01757586
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model, Eur Respir J, vol.50, issue.2, 2017. ,
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension, Eur Heart J, vol.39, issue.47, pp.4175-81, 2017. ,
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.53, issue.6, p.1802004, 2019. ,
Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension, Am J Cardiol, vol.104, issue.6, pp.868-72, 2009. ,
Association of anemia and long-term survival in patients with pulmonary hypertension, Int J Cardiol, vol.150, issue.3, pp.291-296, 2011. ,
Iron deficiency is common in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.37, issue.6, pp.1386-91, 2011. ,
Iron deficiency in patients with idiopathic pulmonary arterial hypertension, Heart Lung Circ, vol.23, issue.3, pp.287-92, 2014. ,
Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension, Eur Respir Rev Off J Eur Respir Soc, vol.24, issue.136, pp.263-71, 2015. ,
Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data, Chest, vol.81, issue.2, pp.151-159, 1982. ,
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients, Eur Respir J, vol.52, issue.5, 2018. ,
Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.38, issue.8, pp.833-875, 2019. ,
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure, Circulation, vol.98, issue.24, pp.2709-2724, 1998. ,
Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation, vol.103, pp.2839-2883, 2001. ,
Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice, Am J Physiol Lung Cell Mol Physiol, vol.306, issue.11, pp.986-995, 2014. ,
Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats, Can J Physiol Pharmacol, vol.91, issue.1, pp.38-44, 2013. ,
Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia, J Appl Physiol Bethesda Md, vol.100, issue.1, pp.20-25, 1985. ,
The pathogenesis of pulmonary hypertension -an update, Swiss Med Wkly, 2015. ,
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure, J Am Coll Cardiol, vol.42, issue.5, pp.861-869, 2003. ,
Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension, BMC Pulm Med, vol.16, issue.1, p.145, 201611. ,
Effects of a Rehabilitation Program on Skeletal Muscle Function in Idiopathic Pulmonary Arterial Hypertension, J Cardiopulm Rehabil Prev, vol.30, issue.5, pp.319-342, 2010. ,
Rehabilitation in patients with pulmonary arterial hypertension, Swiss Med Wkly, vol.147, p.14462, 2017. ,
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferatoractivated receptor-gamma activation. Circulation, vol.115, pp.1275-84, 2007. ,
Exercise training contributes to H2O2/VEGF signaling in the lung of rats with monocrotalineinduced pulmonary hypertension, Vascul Pharmacol, vol.87, pp.49-59, 2016. ,
Principles of Rehabilitation and Reactivation: Pulmonary Hypertension, Respiration, vol.89, issue.4, pp.265-73, 2015. ,
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis. Circ Heart Fail, vol.8, pp.1032-1075, 2015. ,
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial, Eur Heart J, vol.37, issue.1, pp.35-44, 2016. ,
Exercise-based rehabilitation programmes for pulmonary hypertension, 2017. ,
,
Economic Evaluation of Exercise Training in Patients with Pulmonary Hypertension, Lung, vol.192, issue.3, pp.359-66, 2014. ,
Is exercise good for the right ventricle? Concepts for health and disease, Can J Cardiol, vol.31, issue.4, pp.502-510, 2015. ,
Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction, Chest, vol.149, issue.5, pp.1252-60, 2016. ,
Exercise training in pulmonary arterial hypertension, J Thorac Dis, vol.10, issue.1, pp.508-529, 2018. ,
Measurement of quality of life in pulmonary hypertension and its significance, Eur Respir J, vol.28, issue.4, pp.808-823, 2006. ,
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases, Arthritis Res Ther, vol.14, issue.3, p.148, 2012. ,
Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension, PloS One, vol.7, issue.7, p.41603, 2012. ,
Benefits of Intensive Treadmill Exercise Training on Cardiorespiratory Function and Quality of Life in Patients With Pulmonary Hypertension, Chest, vol.143, issue.2, pp.333-376, 2013. ,
Effects of an Outpatient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study, Cardiovasc Hematol Disord Drug Targets, vol.17, issue.1, pp.3-10, 2017. ,
Primary pulmonary hypertension, Lancet Lond Engl, vol.352, issue.9129, pp.719-744, 1998. ,
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), Eur Heart J, pp.2493-537, 1920. ,
Anxiety and depression in patients with pulmonary hypertension, Psychosom Med, vol.66, issue.6, pp.831-837, 2004. ,
Principles of Rehabilitation and Reactivation, Respiration, vol.89, issue.1, pp.2-11, 2015. ,
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension, Circulation, vol.114, issue.14, pp.1482-1491, 2006. ,
Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension, Respiration, vol.81, issue.5, pp.394-401, 2011. ,
Safety and efficacy of exercise training in various forms of pulmonary hypertension, Eur Respir J, vol.40, issue.1, pp.84-92, 2012. ,
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension, Eur Respir J, vol.34, issue.3, pp.669-75, 2009. ,
ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Heart J, vol.37, issue.1, pp.67-119, 2015. ,
Risk stratification and medical therapy of pulmonary arterial hypertension, Eur Respir J, vol.53, issue.1, 2019. ,
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension, Eur Respir J, vol.50, issue.2, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01757586
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, Eur Respir J, 2019. ,
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients, Eur Respir J, vol.52, issue.5, 2018. ,
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension, Eur Heart J, vol.39, issue.47, pp.4175-81, 2017. ,
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, issue.5, pp.428-461, 2012. ,
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension. Circ Heart Fail, vol.8, pp.1032-1075, 2015. ,
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension, N Engl J Med, vol.373, issue.9, pp.834-878, 2015. ,
Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med, vol.369, issue.9, pp.809-827, 2013. ,
Selexipag for the Treatment of Pulmonary Arterial Hypertension, N Engl J Med, vol.373, issue.26, pp.2522-2555, 2015. ,
Wir sind Betroffene und haben uns mit unseren Freunden zu dem Verein pulmonale hypertonie (ph) e.v. zusammengeschlossen, um den Erkrankten und deren Familien, in ihrem persönlichen Schicksal nach der Diagnose Lungenhochdruck, zu helfen, Gemeinnütziger Selbsthilfeverein, 2019. ,
Principles of Rehabilitation and Reactivation: Pulmonary Hypertension, Respiration, vol.89, issue.4, pp.265-73, 2015. ,
, , 2019.
REHABILITATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION : RESULTS FROM THE GRENOBLE EXPERIENCE ABSTRACT Introduction : For decades, patients with pulmonary hypertension (PH) were advised to avoid exercise in fear of deterioration in right heart function. Since then, recent studies have reported that rehabilitation programme in expert centres may have a specific role in the management of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH), J Thorac Dis, vol.10, issue.1, pp.508-529, 2018. ,
, We also apply a recently validated abbreviated versions of the ESC/ERS pulmonary hypertension risk stratification. Results : 41 patients were included (mean age 59,6 +/-18,1 years-old). The rehabilitation programme improved the risk assessment grade (-0,25 point, 95% CI, -0,45 to -0,07), the NYHA functional class and haemodynamic parameters including mPAP (-6,3 mmHg, 95% CI, -12,3 to -0,3) and right atrial pressure. The 6-minute walk distance improvement exceeded by far the minimal important difference of 33 m, were evaluated retrospectively on functional, biological parameters, and haemodynamics, 2010.